Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qin Zen
Observed name:
Q Zen
Observed institutions:
University of North Carolina at Chapel Hill,
Duke University,
University of Michigan,
Duke Medical Center,
U-M Rogel Cancer Center,
The Ohio State University
show all 6
OpenAlex ID:
A5065014498
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
2012
·
Hasan Korkaya
, Gwang-il Kim
, et al.
·
Molecular Cell
·
540
PDF
HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
2013
·
Suthinee Ithimakin
, Kathleen C. Day
, et al.
·
Cancer Research
·
237
Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin.
1998
·
M Udani
, Q Zen
, et al.
·
Journal of Clinical Investigation
·
215
PDF
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion
2003
·
Patrick C. Hines
, Qin Zen
, et al.
·
Blood
·
180
Critical Factors in Basal Cell Adhesion Molecule/Lutheran-mediated Adhesion to Laminin
1999
·
Qin Zen
, Maisha Cottman
, et al.
·
Journal of Biological Chemistry
·
98
Effect of Human C-Reactive Protein on Chemokine and Chemotactic Factor-Induced Neutrophil Chemotaxis and Signaling
1998
·
Wangjian Zhong
, Qin Zen
, et al.
·
The Journal of Immunology
·
79
B‐CAM/LU expression and the role of B‐CAM/LU activation in binding of low‐ and high‐density red cells to laminin in sickle cell disease
2004
·
Qin Zen
, Milena Batchvarova
, et al.
·
American Journal of Hematology
·
36
PDF
Molecular interactions of B-CAM (basal-cell adhesion molecule) and laminin in epithelial skin cancer
2004
·
Claudia Drewniok
, B. Gregor Wienrich
, et al.
·
Archives of Dermatological Research
·
27
Binding site on human C-reactive Protein (CRP) recognized by the Leukocyte CRP-receptor
1997
·
Qin Zen
, Wangjian Zhong
, et al.
·
Journal of Cellular Biochemistry
·
18
Abstract 3470: HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: Implications for efficacy of adjuvant trastuzumab
2012
·
Fayaz Malik
, Suthinee Ithimakin
, et al.
·
Cancer Research
·
1
Supplementary Methods, Figures 1 - 7 from HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
2023
·
Suthinee Ithimakin
, Kathleen C. Day
, et al.
Data from HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
2023
·
Suthinee Ithimakin
, Kathleen C. Day
, et al.
Supplementary Methods, Figures 1 - 7 from HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
2023
·
Suthinee Ithimakin
, Kathleen C. Day
, et al.
PDF
Data from HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
2023
·
Suthinee Ithimakin
, Kathleen C. Day
, et al.
Abstract 4268: Breast cancer stem cells play a role in trastuzumab resistance in mouse xenograph models
2010
·
Korkaya Hasan
, Amanda K. Paulson
, et al.
·
Cancer Research
Characterization, Identification and Cloning of The C-Reactive Protein Receptor on Human Monocyte /
1996
·
Qin Zen
·
OhioLink ETD Center (Ohio Library and Information Network)
PDF
Show more works
View as search
Works count:
16
Citation count:
1,431
H-index:
9
I10-index:
9
Year
Topic
Type
